Yahoo Web Search

    • Here's Why I Bought This Recent Genetics IPO

      Motley Fool· 3 days ago

      Consumer genetics testing company 23andMe Holding (NASDAQ: ME) recently went public via special purpose acquisition company merger, and longtime Fool.com contributor Matt Frankel, CFP, jumped ...

    • Providers wait for COVID treatment

      Crossville Chronicle, Tenn. via Yahoo News· 5 days ago

      Sep. 20—As new cases of COVID-19 have surged in the Southeast, health care leaders, governors and others have urged patients to seek out a treatment that can help patients fend off more serious ...